Valeant Pharma extends exchange offer to acquire all of the outstanding shares of Allergan (AGN) to December 31, 2014
Co announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan (AGN) to 5:00 p.m., New York City time, on December 31, 2014. The exchange offer was previously scheduled to expire at 5:00 p.m., New York City time today, Friday, August 15, 2014. All other terms and conditions of the exchange offer remain unchanged.